why choose us

First received: March 08, 2024

Clinical Trial: A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Respiratory Syncytial Virus

Study Type: INTERVENTIONAL


Official Title: A PHASE 3, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN PREGNANT PA

Brief Summary: The purpose of the study is to learn about the safety and immune activity of the RSVpreF vaccine.It will be studied in infants born to mothers living with HIV.These infants may have higher chances of getting sick or dying due to RSV infection.Respiratory Syncytial Virus (RSV) is a common type of virus (germ) that can cause severe illness (airway diseases), where medical help is needed.Vaccines help your body make antibodies which help fight against diseases.The antibodies are substances your body uses to fight off…

Read more